Longstanding cannabis producer Solstice Group has operated in Seattle since 2011 and claims historical firsts as the first fully permitted medical cannabis production facility in 2012, indicating established market presence and credibility that can be leveraged in B2B partnerships or wholesale expansions.

Retail and processing focus The company produces and processes cannabis and related products for sale at medical cannabis stores, suggesting opportunities to upsell packaging, branding services, or product diversification for retailers and potential collaborations with dispensaries and medical channels.

Mid-market scale With 11-50 employees and revenue in the one to ten million range, Solstice sits in a mid-market segment where targeted sales motions, channel partnerships, and scalable solutions (logistics, compliance tech, and payroll or HR systems) can yield efficient conversions.

Tech stack reuse Current technology stack includes JazzHR, WordPress, and PHP among others, signaling openness to software and service partnerships in recruitment, website optimization, e-commerce enhancements, and digital marketing support that align with their online presence.

Media and investor activity Frequent coverage in business and defense outlets and recent stock-related news imply visibility to investors and partners; this presents an opportunity for sponsorships, investor relations services, or strategic communications firms to engage with Solstice or its affiliate entities.